Cargando…

DCs-based therapies: potential strategies in severe SARS-CoV-2 infection

Pneumonia caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is spreading globally. There have been strenuous efforts to reveal the mechanisms that the host defends itself against invasion by this virus. The immune system could play a crucial role in virus infection. Dendriti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jian, Sun, Jiazhi, Zhang, Guixin, Chen, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757148/ https://www.ncbi.nlm.nih.gov/pubmed/33390810 http://dx.doi.org/10.7150/ijms.47706

Ejemplares similares

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
por: Bouadma, Lila, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

Potential Anti-SARS-CoV-2 Molecular Strategies
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
por: He, Li-Hong, et al.
Publicado: (2020)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

tDCS as telehealth intervention to reach patients with Post-Acute Sequelae of SARS-CoV-2 (PASC)
por: Charvet, Leigh, et al.
Publicado: (2023)

Prevention and Control Strategies for SARS-CoV-2 Infection
por: Srivastava, Nishant, et al.
Publicado: (2020)

The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection
por: Hu, Jiulue, et al.
Publicado: (2021)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

Severe SARS-CoV-2 infection in critical care
por: Fernández-Sarmiento, Jaime, et al.
Publicado: (2020)

Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020)

Mortality Predictors in Severe SARS-CoV-2 Infection
por: Lazar, Mihai, et al.
Publicado: (2022)

Prognostic factors for the severity of SARS-CoV-2 infection
por: Rubio-Sánchez, Ricardo, et al.
Publicado: (2021)

Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection()()
por: O'Moráin, N, et al.
Publicado: (2022)

Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity
por: Zhang, Zai-qiang, et al.
Publicado: (2022)

Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity
por: Zhang, Zai-qiang, et al.
Publicado: (2022)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

SARS-CoV-2 Omicron infection, who will be developed into severe/critical diseases?
por: Feng, Mudan, et al.
Publicado: (2023)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy
por: Domínguez-Ortega, Javier, et al.
Publicado: (2020)

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
por: Eger, Katrien, et al.
Publicado: (2021)

Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets
por: Illian, Didi Nurhadi, et al.
Publicado: (2021)

Potential zoonotic sources of SARS‐CoV‐2 infections
por: Jo, Wendy K., et al.
Publicado: (2020)

Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
por: Chekol Abebe, Endeshaw, et al.
Publicado: (2022)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
por: Skayem, Charbel, et al.
Publicado: (2020)

Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection
por: Pan, Simon, et al.
Publicado: (2020)

Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
por: Castillo, P.R., et al.
Publicado: (2020)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
por: Abenza-Abildúa, María José, et al.
Publicado: (2020)

SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy
por: Kristoffersen, Aslak Widerøe, et al.
Publicado: (2020)

An immune correlate of SARS-CoV-2 infection and severity of reinfections
por: Maier, Hannah E., et al.
Publicado: (2021)

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Roles of the gut microbiota in severe SARS-CoV-2 infection
por: Liu, Yiran, et al.
Publicado: (2022)

Transient severe neutropenia in an infant with SARS-CoV-2 infection
por: Irie, Shinji, et al.
Publicado: (2022)

Increased severity in SARS-CoV-2 infection of minorities in Spain
por: Carbó, Adrián Valls, et al.
Publicado: (2021)

Otolaryngologic Symptom Severity Post SARS-CoV-2 Infection
por: Bouldin, Emerson, et al.
Publicado: (2023)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1n4imi59t7qt98rok893tqe83t